Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 30 June 2025

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 53 Euro (EUR) 17 Renminbi (CNY) 12 Indian rupee (INR) 8 Swiss franc (CHF) 6 Other currencies (CAD, DKK, GBP, HDK, SEK) 4 #8aacb4 #3e395b #ebbe1a #a00f3b #52755e #8c74af #00a4c8 #dc6c3f #cab415 #423e3d
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Private companies 33 Public (from private) companies 26 Public companies 22 Funds 10 Cash and cash equivalents 5 Other assets 4 #8aacb4 #3e395b #ebbe1a #a00f3b #52755e #8c74af #00a4c8 #dc6c3f #cab415 #423e3d
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Profitable 51 Products on the market 15 Phase I 5 Phase II 19 Phase III 8 Preclinical 2 #8aacb4 #3e395b #ebbe1a #a00f3b #52755e #8c74af #00a4c8 #dc6c3f #cab415 #423e3d
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 34 Oncology 17 Synthetic biology 13 Central nervous system 12 Immunology/Inflammation 8 Orphan diseases 6 Digital Health 5 Medical technology / diagnostics 5 #8aacb4 #3e395b #ebbe1a #a00f3b #52755e #8c74af #00a4c8 #dc6c3f #cab415 #423e3d